Recruiting NA INTERVENTIONAL 1-arm
NCT07177482
ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients
Sponsor: Deling Li
Conditions
Craniopharyngioma
Interventions
68Ga-MY6349 PET/CT
Updated 1 time since 2025 Last updated: Sep 10, 2025 Started: Jul 4, 2025 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Craniopharyngioma and is currently actively recruiting participants. Deling Li leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Deling Li
- Peking Union Medical College Hospital
Data source: Beijing Tiantan Hospital
For direct contact, visit the study record on ClinicalTrials.gov .